⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL84537 | 1.00 | — | — | |
| SCHEMBL4449549 | 0.95 | — | — | |
| Phosphine SCHEMBL28283196 | 0.95 | — | — | |
| SCHEMBL5050148 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL1366326 | 0.95 | — | — | |
| Thiophene SCHEMBL28138545 | 0.77 | — | — | |
| SCHEMBL2691891 | 0.74 | — | — | |
| SCHEMBL18321327 | 0.74 | — | — | |
| SCHEMBL22230554 | 0.74 | — | — | |
| SCHEMBL22230566 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7599 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| US-20240343697-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2024-10-17 | — | — | US | claimed |
| WO-2023229859-A1 | PROCESS TO PRODUCE HEXAHYDRO-1,3,5-TRINITRO-1,3,5-TRIAZINE AND OCTAHYDRO-1,3,5,7-TETRANITRO-1,3,5,7-TETRAZOCINE WITH DIRECT RECYCLE OF SPENT ACID | PHILLIPS JAMES E (US) | 2023-11-30 | — | — | WO | claimed |
| US-11345956-B2 | Methods and compositions related to prostate cancer therapeutics | THE JOHNS HOPKINS UNIVERSITY (US) | 2022-05-31 | — | — | US | claimed |
| US-11207289-B2 | Use of benzofuran lignans to induce IL-25 expression and suppress mammary tumor metastasis | ACADEMIA SINICA (TW) | 2021-12-28 | — | — | US | claimed |
| US-10953073-B2 | XTEN conjugate compositions and methods of making same | AMUNIX PHARMACEUTICALS, INC. (US) | 2021-03-23 | — | — | US | claimed |
| US-20210060040-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2021-03-04 | — | — | US | claimed |
| EP-3191114-B1 | OCCIDIOFUNGIN FORMULATIONS AND USES THEREOF | UNIV MISSISSIPPI STATE (US) | 2021-03-03 | — | — | EP | claimed |
| US-20200289454-A1 | USE OF BENZOFURAN LIGNANS TO INDUCE IL-25 EXPRESSION AND SUPPRESS MAMMARY TUMOR METASTASIS | Yang, Ning-Sun (TW) | 2020-09-17 | — | — | US | claimed |
| WO-2004000219-A2 | STABILIZED FORMULATIONS OF ALPHA ADRENERGIC RECEPTOR ANTAGONISTS AND USES THEREOF | NOVALAR PHARMACEUTICALS, INC. (US) | 2003-12-31 | — | — | WO | claimed |
| US-20030236306-A1 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof | NOVALAR PHARMACEUCTICALS,INC. | 2003-12-25 | — | — | US | claimed |
| EP-1351678-A2 | TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS | Shanahan-Prendergast, Elizabeth (IE) | 2003-10-15 | — | — | EP | claimed |
| EP-1280531-A1 | LOCAL ANESTHETIC METHODS AND KITS | Novalar Pharmaceuticals, Inc. (US) | 2003-02-05 | — | — | EP | claimed |
| US-20020183396-A1 | Administering to a mammal in need of an anesthetic agent and an alpha adrenergic receptor agonist to the site to be anesthetized to constrict the blood vessels at the site and prolong the local anestheia, then administering an antagonist | NOVALAR PHARMACEUTICALS, INC. | 2002-12-05 | — | — | US | claimed |
| US-20020183356-A1 | Administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist | NOVALAR PHARMACEUTICALS, INC. | 2002-12-05 | — | — | US | claimed |
| WO-2002053138-A2 | TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS | SHANAHAN-PRENDERGAST ELISABETH (IE) | 2002-07-11 | — | — | WO | claimed |
| US-20010056125-A1 | Local anesthetic methods and kits | NOVALAR PHARMACEUTICALS, INC. | 2001-12-27 | — | — | US | claimed |
| WO-2001085171-A1 | LOCAL ANESTHETIC METHODS AND KITS | NOVALAR PHARMACEUTICALS, INC. (US) | 2001-11-15 | — | — | WO | claimed |
| US-3987034-A | NITRATION OF A PENTAMETHYLENETETRAMINE DERIVATIVE | IDAHO RESEARCH FOUNDATION, INC. (US) | 1976-10-19 | — | — | US | claimed |